Vol 95, No 9 (2024)
Research paper
Published online: 2023-11-27

open access

Page views 1130
Article views/downloads 621
Get Citation

Connect on Social Media

Connect on Social Media

ORIGINAL PAPER / OBSTETRICS

Ginekologia Polska

2024, vol. 95, no. 9, 693–704

Copyright © 2024 PTGiP

ISSN 0017–0011, e-ISSN 2543–6767

DOI: 10.5603/gpl.92940

Intrauterine deaths — an unsolved problem in Polish perinatology

Tomasz Gora12Kamila A. Wojtowicz1Maja Drozdzak1Pawel Guzik1Jakub Kornacki3Katarzyna Kosinska-Kaczynska4Anna Kajdy56Dorota Sys56Stepan Feduniw5Przemyslaw Kosinski7Anna Szczepkowska8Dorota Darmochwal-Kolarz9Pawel Tos9Tomasz Kluz10Anna Zymroz10Magda Rybak-Krzyszkowska2Hubert Huras2Boguslawa Piela11Marzena Malec11Ewa Banas-Fiebrich11Ewa Janowska-Tyc11Katarzyna Stefanska12Malgorzata Swiatkowska-Freund13Agnieszka Mrozinska12Magdalena Bednarek-Jedrzejek14Aleksandra Kukla14Dominika Boboryko14Urszula Warejko14Sebastian Kwiatkowski14
1Clinical Department of Gynecology and Obstetrics, John Paul II Municipal Hospital in Rzeszow, Poland
2Clinical Department of Obstetrics and Perinatology, University Hospital of the CMUJ in Cracow, Poland
3Clinical Department of Reproduction and Perinatal Medicine, Gynecology And Obstetrics Clinical Hospital, Medical University in Poznan, Poland
4Department of Obstetrics, Perinatology and Neonatology, Center of Postgraduate Medical Education in Warsaw, Poland
5Department of Pregnancy Pathology, Zelazna Medical Center — Specialist Hospital St. Zofia in Warsaw, Poland
6Department of Reproductive Health CMKP in Warsaw, Poland
7Clinical Department of Obstetrics, Perinatology and Gynecology, University Clinical Center, Medical Uniwersity in Warsaw, Poland
8University Center of Women’s and Newborn’s Health in Warsaw, Poland
9Clinical Department of Gynecology, Obstetrics and Perinatology, Provincial Clinical Hospital No 2 in Rzeszow, Poland
10Clinical Department of Gynecology and Obstetrics, University Hospital them. Fryderyk Chopin in Rzeszow, Poland
11Clinical Department of Gynecology, Obstetrics and Perinatology, Provincial Municipal Hospital in Ruda Slaska, Poland
12Department of Gynecology and Obstetrics, Medical University in Gdansk, Poland
13Academy of Applied Medical and Social Sciences in Elblag, Poland
14Department of Obstetrics and Gynecology, Independent Public Clinical Hospital, No 2, Medical University in Szczecin, Poland

Corresponding author:

Kamila Wojtowicz

Clinical Department of Gynecology and Obstetrics, John Paul II Municipal Hospital in Rzeszow, Poland

e-mail: guccii@poczta.onet.pl

Received: 12.06.2023 Accepted: 28.06.2023 Early publication date: 27.11.2023

This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.

ABSTRACT

Objectives: The Polish criteria for “intrauterine death” include fetal demise after 22 weeks of gestation, weighing > 500 g and body length at least 25 cm, when the gestational age is unknown. The rate of fetal death in Poland in 2015 is 3:10,000. In 2020, 1,231 stillbirths were registered.

Material and methods: An analysis using 142,662 births in the period between 2015–2020 in 11 living in Poland. The first subgroup was admitted as patients > 22 to the beginning of the 30th week of pregnancy (n = 229), and the second from the 30th week of pregnancy inclusively (n = 179). In the case of women from both subgroups, there was a risk of preterm delivery close to hospitalization.

Results: It was found that stillbirth in 41% of women in the first pregnancy. For the patient, stillbirth was also the first in his life. The average stillbirth weight was 1487 g, the average body length was 40 cm. Among fetuses up to 30 weeks, male fetuses are born more often, in subgroup II, the sex of the child was usually female. Most fetal deaths occur in mothers < 15 and > 45 years of age.

Conclusions: According to the Polish results of the origin of full-term fetuses > 30 weeks of gestation for death in the concomitant antenatal, such as placental-umbilical and fetal hypoxia, acute intrapartum effects rarely, and moreover < 30 Hbd fetal growth restriction (FGR), occurring placental-umbilical, acute intrapartum often.

Keywords: stillbirth; intrauterine deaths; newborn deaths

Ginekologia Polska 2024; 95, 9: 693–704

INTRODUCTION

The problem of intrauterine foetal deaths is one of the keys, and at the same time not fully explored, issues faced by specialists in maternal-foetal medicine. The final determination of risk factors and conditions in which such events occur still requires a lot of research, making it is possible to develop effective methods of prevention, stopping the unfavourable termination of pregnancy as much as possible.

Currently, according to the available literature, the term stillbirth is synonymous with foetal death before birth, and the criteria for diagnosis, including the weight of the child and its length, vary depending on the source and the recommendations applicable in a given country [1].

According to the definition of the World Health Organization (WHO), stillbirth is defined as the death of a foetus weighing more than 1,000 g or if a foetus over 28 weeks of gestation and reaching a body length of more than 35 cm [2]. The US National Center for Health Statistics defines foetal death as the delivery of a newborn with no signs of life, as indicated by no breathing, no heartbeat, no pulsation of the umbilical cord or no clear muscle movement.

There are no uniform criteria for reporting stillbirths. In Świecie, the suggested age of registered stillbirths applies to newborns after 20 weeks of gestation or later (if the gestational age is known) or a weight of at least 350 grams, if the gestational age is not known. The limit of 350 grams is the 50th percentile of weight in the 20th week of pregnancy [3].

In Poland, the term “intrauterine death” includes foetal death after 22 weeks of gestation, a weight > 500 g and body length of at least 25 cm, when the gestational age is unknown [4]. Foetal demise > 22 weeks of gestation may refer to early pregnancy (completed 22 weeks to 27 + 6 weeks) and late pregnancy (completed 28 weeks).

There are nearly two million stillbirths worldwide every year. It is estimated that, on average, 1 child dies every 16 seconds. The above figures are based on WHO and UN reports. It is important to remember that behind these statistics lie the tragedies of women and their families. The result of these traumatic experiences may be severe depressive episodes not covered by psychological assistance within the framework of regional or global healthcare financing programmes [5].

More than 40% of all intrauterine deaths occur during childbirth. These are events that could often have been avoided due to routine monitoring of the course of pregnancy, especially those high-risk. This should be done, according to specific standards, continuous work on improving the quality of perinatal care and, what is extremely important, quick access to obstetric care in cases requiring urgent intervention [6]. One of the most common causes of stillbirth is preterm birth. Intrauterine foetal death may be the result of complications related to the course of pregnancy, delivery, intrauterine infection, placental insufficiency or maternal diseases: arterial hypertension, diabetes and/or smoking. Foetal defects are the cause of no more than 10% of stillbirths [7].

The causes of foetal death can be divided into foetal (genetic factors, non-immune hydrops fetalis, infection and multiple pregnancy), placental [premature rupture of membranes, premature separation of the placenta, abnormal implantation and placental failure, umbilical cord collision and twin to twin transfusion syndrome (TTTS) syndrome], maternal (uterine defects, maternal age > 40 years, maternal diseases such as diabetes, thrombophilia, hypertension, kidney and thyroid diseases, uterine defects, overweightness, smoking, addiction, infection, overdue pregnancy, injuries and birth complications) and other factors (socioeconomic, low level of perinatal care and various unknowns).

It has been estimated that the number of registered stillbirths may still increase due to the difficult access to medical care caused by the COVID-19 pandemic. The role of preventive vaccinations in preventing this phenomenon is emphasized [8]. Statistically, 84% of all births occur in low- and middle-income countries. In high-income countries, the problem of intrauterine deaths mainly affects national minorities [9].

According to WHO data from 2015, the incidence of intrauterine deaths in the world is as high as 18.8:1000 of all deliveries. In the USA, this ratio is 6.25, while in European countries, it does not exceed 6. In England, Wales and Northern Ireland, the rate of intrauterine deaths is 5:1000, while in Poland, it is just over 3:1000, which is similar to France, Belgium and Hungary. Only the Czech Republic, Germany, Sweden, Norway and Finland can boast about their better perinatal care results [10].

Analysing the statistics from 2020, 1,231 stillbirths were registered in Poland. Data from the database of the Central Statistical Office include the mother’s age, child’s sex, place of residence and the consecutive pregnancy number [11]. So far, the problem of stillbirth has not been addressed on a large scale in the Polish literature. There are no analyses involving multicentre data. We do not have information on the most common causes of this phenomenon in recent years. The state of medical records, which could provide answers to many questions, was also not assessed.

The above information could be used to develop a Polish classification of stillbirth causes. This classification should be based on the evaluation of health, cultural and economic factors, on the verification of competence and commitment of medical personnel. It seems that a too high a percentage of stillbirths is not registered at all, and thus, parents are not issued a birth certificate. This is a significant moral and ethical problem related to the trauma of losing a child and the financial consequences of the resulting health issues. Stillbirth can be somewhat prevented by proper education of future parents and rational family planning, pre-conception care, including care for good health and nutrition of women at reproductive age, high quality of medical care, as well as by the appropriate level of qualifications of medical personnel and financing the system healthcare.

This study is an attempt to assess the current state of medical care in Poland in the context of stillbirths. It is to be one of the first to attempt to highlight this issue and be a step towards proposing an appropriate standard of conduct in pre- and post-conception care.

Research aim

Stillbirth is an issue that has not been addressed in Polish literature so far [4, 12]. Due to the lack of detailed data from centres across the country, it is impossible to reliably assess the causes and discuss the prevention of this phenomenon. This paper is an attempt to evaluate the quality of medical records kept at clinical centres, their completeness, and thus, the credibility of existing statistics on the incidence of stillbirths in the Polish population.

MATERIAL AND METHODS

Eleven clinical centres from all over the country participated in the study regarding the phenomenon of stillbirths in Poland. The observation covered a period of 5 years (2015–2020). Medical records of 142,662 deliveries were analysed. We found 761 cases in which the patient gave birth to a dead foetus. The criteria for exclusion from analysis were multiple pregnancy, undetermined gestational age > 22 weeks, undetermined gender of the child, lack of data on foetal weight, status after intrauterine therapy, abnormal karyotype and presence of foetal malformations. Ultimately, 408 cases were evaluated. For research purposes, this group of women was divided into two subgroups depending on the gestational age. The first subgroup included patients > 22 up to the beginning of the 30th week of pregnancy (n = 229), and the second one from the 30th + week of pregnancy (n = 179). In the case of women from both sub-groups, the reason for hospitalisation was the risk of pre-term delivery. Based on the classification of stillbirth causes in the prenatal period proposed by WHO (ICD-PM), 3 groups were distinguished: antenatal, perinatal and maternal diseases.

The following factors were taken into account in the analysis: maternal risk factors: high weight of the patient and high body mass index (BMI) before pregnancy and at the time of admission to hospital (BMI > 30), high weight gain of the pregnant woman, pregnancy and delivery number, method of delivery, post-caesarean section, intrauterine infections, gestational diabetes, pregnancy-induced hypertension, chronic hypertension, preeclampsia, HELLP syndrome, cholestasis of pregnancy and premature placental abruption. Potential foetal risk factors for stillbirth included: foetal growth disorders (SGA and FGR), intrauterine infections as well as pre- and perinatal hypoxia.

Data on the course of pregnancies were obtained based on reviewing pregnancy charts, medical history and physical examination of the hospitalised patients. The diagnosis of stillbirth was made based on confirming the absence of foetal heartbeat in ultrasound examination, and in the presence of two physicians. The decision regarding the choice of delivery route was made based on the current obstetric situation. Qualification for delivery by caesarean section was carried out in the event of a threat to the life and/or health of the pregnant woman and/or foetus, based on the current recommendations of the Polish Society of Gynaecologists and Obstetricians. Clinical cases of 408 patients who gave birth to a stillborn child in 2015–2020 were analysed. Sub-group 1 included patients with intrauterine death > 22 and < 30 weeks of gestation consisted of 229 patients — 56%. Sub-group 2 consisted of patients in whom foetal demise occurred the earliest in the 30th week of pregnancy included 179 women — 44%. Detailed data on pregnant women and newborns are presented in Table 1.

Table 1. Clinical characteristics of the study group of patients

Study group n = 408

Sub-group 1 < 30 HBD n = 229

Sub-group 2 ≥ 30 HBD n = 179

p value

Mean/N

SD/[%]

Mean/n

SD/[%]

Mean /N

SD/[%]

Height

165

6.271

165

6.475

165

5.993

0.695

Pre-pregnancy body mass

65

13.335

66

14.470

64

12.409

0.395

Pre-pregnancy BMI

23

4.607

23

4.147

24

5.118

0.095

Body mass at admission

73

14.781

71

14.083

76

76.757

0.001

Gestational weight gain-GWG

8

5.662

6

4.463

11

5.790

0.000

Foetus weight

1487

1109.169

736

459.663

2448

942.682

0.000

Foetus length

40

10.916

32

7.704

48

6.931

0.000

State after CS

After 1

82

20.10

44

19.21

38

21.23

0.629

After 2

3

0.73

1

0.43

2

1.11

Pregnancy

1

168

41.18

100

43.67

68

37.99

0.582

2

114

27.94

63

27.51

51

28.49

3

74

18.14

37

16.16

37

20.67

4 and more

52

12.74

29

12.66

23

12.85

Delivery

1

215

52.70

125

54.59

90

50.27

0.828

2

109

26.71

60

26.20

49

27.37

3

57

13.97

30

13.10

27

15.03

4 and more

27

6.62

14

6.11

13

7.26

Type of delivery

Natural

338

82.84

200

87.34

138

77.09

0.006

Caesarean section

70

17.16

29

12.66

41

22.91

Sex of foetus

Male

215

52.70

131

57.21

84

46.93

0.039

Female

193

47.30

98

42.79

95

53.07

Gestational diabetes-GDM1

20

4.90

9

3.93

11

6.15

0.303

Gestational diabetes-GDM2

14

3.43

4

1.75

10

5.59

0.344

Pregnancy hypertension-GH

26

6.37

11

4.80

15

8.38

0.142

Chronic gestational hypertension- CGH

26

6.37

17

7.42

9

5.03

0.325

Preeclampsia-PE

16

3.92

12

5.24

4

2.23

0.121

HELLP

2

0.49

2

0.87

0

0

0.210

Gestational cholestasis

3

0.74

0

0

3

1.66

0.049

Premature placental abruption

31

7.60

14

6.11

17

9.50

0.200

Diagnosed FGR

107

26.23

76

33.19

31

17.32

0.000

Diagnosed SGA

33

8.09

19

8.30

14

7.82

0.861

HELLP — hemolysis, elevated liver enzymes, low platelets syndrome; FGR — fetal growth restriction; SGA — small for gestational age

Clinical characteristics of patients in both sub-groups included height, weight, pre-pregnancy body BMI, weight at admission and weight gain during pregnancy. Statistically significant differences were observed in terms of BMI before pregnancy (p = 0.095) — subgroup I — n = 23 kg/m2, subgroup II — n = 24 kg/m2, weight at admission to hospital (p = 0.001, n = 71 kg vs 76 kg) and weight gain during pregnancy (p = 0.000, n = 6 kg vs 11 kg).

The obstetric history was also analysed. Attention was paid to the sequential number of pregnancies and childbirths, the birth of a child via caesarean section and the number of these procedures in the past, as well as the way of completing the current pregnancy in which intrauterine foetal death occurred. In the study group, stillbirths occurred in 41% of women in the first pregnancy (sub-group 1 — 43.67%, sub-group 2 — 37.99%). For the majority of patients — 52.70%, this was their first stillbirth (54.59% vs 50.27%). One-fifth of the patients (82 people) gave birth by caesarean section at least once (19.21% vs 21.23%). Stillbirth in most women was vaginal (82.84% — 87.34% vs 77.09%). This difference was of statistical significance (p = 0.006).

Assessment of stillbirth included sex, birth weight and length. The mean stillbirth weight was 1,487 g (736 g vs 2,448 g, p = 0.000) and mean body length was 40 cm (32 cm vs 48 cm, p = 0.000). Differences between sub-groups were statistically significant. Male newborns were delivered more often — 52.7%, however, in sub-group 2, the sex of the child was usually female — 53.07%. These differences were also statistically significant (p = 0.039).

Pregnancy complications were also assessed: gestational diabetes mellitus type 1 and 2, pregnancy-induced and chronic hypertension, preeclampsia, HELLP syndrome, gestational cholestasis, premature placental abruption and foetal growth disorders (SGA and FGR). Statistically significant differences were observed between sub-groups in the incidence of gestational cholestasis (0% vs 1.66%, p = 0.049) and intrauterine growth retardation (33.19% vs 17.32%). An attempt was made to analyse the causes of intrauterine deaths, based on the WHO ICD-PM classification (Tab. 2).

Table 2. ICD-PM classification of stillbirths causes according to WHO

Pre-birth causes

A1

Congenital defects, deformities and chromosomal aberrations

A2

Infection

A3

Antenatal hypoxia

A4

Other pre-natal abnormalities

A5

Foetal growth disorders

A6

Antenatal death of unknown cause

N1

Congenital defects, deformities and chromosomal aberrations

N2

Foetal growth disorders

N3

Perinatal trauma

N4

Complications of perinatal incidents

N5

Convulsions and diseases of the central nervous system

N6

Infection

N7

Disorders of the circulatory and respiratory systems

N8

Other conditions of the newborn

N9

Low birth weight and prematurity

N10

Varied

N11

Unknown cause of newborn death

Perinatal causes

I1

Congenital defects, deformities and chromosomal aberrations

I2

Antenatal trauma

I3

Acute perinatal incident

I4

Infection

I5

Other perinatal causes of death

I6

Foetal growth disorders

I7

Perinatal death of unknown cause

Mother’s illness

M1

Complications of the placenta, umbilical cord and membranes

M2

Mother-related pregnancy complications

M3

Other delivery-related complications

M4

Medical and surgical conditions of the mother

M5

No determined illness of mother

The incidence of particular causes of stillbirth was analysed based on the division into antenatal, perinatal and maternal factors. The observations are presented in the tables. It turned out that in the case of foetal death before delivery, in 56.62% of cases, the cause of death could not be determined (Fig. 1) (sub-group I — 53.71% vs sub-group II — 60.34%, p = 0.000). In cases where the cause of death could be identified, in sub-group 1, 59 cases (25.76%) were determined as foetal growth disorders, while in sub-group 2, foetal hypoxia occurred in 29 women (16.2%) (Fig. 2, 3). In the case of foetal death during delivery, the most common cause, both in the entire study group (2.7%) and in the first (3.06%) and second sub-groups (2.24%), was an acute perinatal event (Fig. 4, 5). It was found that in the case of foetal demise, in 45.1% of cases, no disease was found in the pregnant woman (Fig. 6) (sub-group I–1 — 44.54% vs sub-group 2 — 45.81%, p = 0.000) (Fig. 7).

Figure 1. Determining cause of death
Figure 2. Antenatal causes of intrauterine deaths
Figure 3. Antenatal causes of intrauterine deaths depending on gestational age
Figure 4. Perinatal causes of intrauterine deaths
Figure 5. Perinatal causes of intrauterine deaths depending on gestational age
Figure 6. Maternal causes of intrauterine deaths
Figure 7. Perinatal causes of intrauterine deaths depending on gestational age

Table 3. Causes of intrauterine deaths in the study group according to WHO

Study group n = 408

Sub-group 1 < 30 HBD n = 229

Sub-group 2 ≥ 30 HBD n = 179

p value

Mean/N

SD/[%]

Mean/N

SD/[%]

Mean/N

SD/[%]

Antenatal cause of death

A2

13

3.19

8

3.49

5

2.79

0.000

A3

46

11.27

17

7.42

29

16.20

A4

21

5.14

11

4.80

10

5.59

A5

79

19.36

59

25.76

20

11.17

A6

231

56.62

123

53.71

108

60.34

Perinatal cause of death

I2

2

0.49

2

0.87

I3

11

2.70

7

3.06

4

2.24

I4

1

0.25

1

0.45

I6

3

0.74

1

0.44

2

1.18

I7

1

0.25

1

0.56

Mother’s illness

M1

98

24.02

59

25.76

39

21.78

0.000

M2

38

9.31

24

10.48

14

7.82

M3

7

1.72

4

1.75

3

1.68

M4

81

19.85

40

17.47

41

22.91

M5

184

45.10

102

44.54

82

45.81

Table 4. Diagnostic algorithm for proceeding in the case of death in the 2nd or 3rd trimester

1/ Research on the mother

2/ Fetal research

3/ Afterbirth research

  1. Maternal Research Section:
    1. Ultrasound examination with an attempt at the most accurate possible anatomical assessment of the dead fetus, AFI index, tp flow uterus and placenta
    2. Detailed obstetric history
    3. Biophysical tests: weight, height, weight gain during pregnancy, blood pressure measurement
    4. Laboratory tests: blood group with immune antibody test, complete blood count, CRP, general urine, fasting glucose/HbA1c, TSH, liver tests and bile acids, tests for fetal-maternal transfusion syndrome (Kleinhauer-Betke test or flow cytometry). Tests for toxoplasmosis, CMV, rubella, Parvovirus B19, syphilis, unless the results obtained earlier indicate a history of infection
    5. Toxicology tests with a history indicating a risk of using psychoactive substances
    6. Tests for thrombophilia (antiphospholipid syndrome, prothrombin G20210A gene mutation test, factor V Leiden) Tests performed especially in a patient with FGR, preeclampsia, history of VTE

2. Fetal research:

  1. Thorough external examination — see Table 5 — an example of clinical fetal assessment card to be completed by a paediatrician, neonatologist, perinatologist
  2. Securing material for genetic and microbiological research
    • Cord blood, cardiocentesis — microbiological and enzymatic tests
    • Umbilical cord fragment, skin fragment, blood obtained by cardiocoenthesis (depending on the collected material, degree of fetal maceration, karyotype or microarray examination)
    • Autopsy examination
    • Baby gram if any bone anomalies are suspected

3. Macroscopic examination of the afterbirth and microscopic assessment optimally in accordance with the Amsterdam Placental Workshop Group Consensus Statement guidelines [21]

CRP — c-reactive protein; CMV — cytomegalovirus; FGR — fetal growth restriction; VTE — venous thromboembolism

Table 5. Child’s world examination checklist

Control of the child’s clinical examination

Mother’s data [name, surname]

Pregnancy:

  • simple
  • multiple

Baby measurements: (total length of the child)

  • head circuit................................cm
  • body weight..............................g

Address.......................................................................

PESEL number..........................................................

Age...............................................................................

Date of intrauterine death of the fetus

Mouth cavity:

  • correct
  • big
  • small

Genitalia:

Anus: correct/overgrown

Sex: woman/man/untypical

Man:

describe penis/scrotum/testicles

..................................................................

Woman:

describe urethral opening/vaginal entrance/clitoris

..................................................................

[dd/mm/yyyy] ...........................................................................................................................................................................

Degree of fetal maceration:

  • fresh (no exfoliation)
  • mild
  • small
  • moderate
  • advanced

Oral cavity:

  • correct
  • big
  • small

Upper lips:

  • correct
  • cleft

Palate..........................................................................

Jaw...............................................................................

Head/face:

  • correct
  • collapse
  • brainless
  • hydrocephalus
  • other…………………

Ears:

  • correct
  • low-set
  • preauricular galls
  • preauricular dimpl
  • rotation
  • others…………………

Limbs

  • length/shape

Hands:

  • length
  • fingers (number, shape, position, fusion)

Thumbs:

  • number
  • shape
  • position

Eyes:

  • correct
  • prominent
  • sunken
  • far-set eyes
  • close set eyes
  • oblique
  • big/small
  • close lenses/eyelids
  • other............................................................................................

Neck:

.......................................................................................

Chest:

  • correct
  • long
  • short
  • wide
  • describe spina bifida.......................................................................

Fingers nails:

.......................................................................................

Feet:

  • correct/incorrect appearance
  • number of nails
  • space between fingers
  • nails

Nose (correct, small, big, etc.):

  • obstructed
  • unobstructed
  • single
  • other............................................................................................

Abdominal:

  • correct
  • concave
  • bloated
  • hernia
  • gastroschisis

Back:

  • correct
  • spina bifida
  • scoliosis
  • kyphosis

DISCUSSION

In Poland, a standard of conduct in the case of stillbirth pregnancies has not yet been developed. In order to understand the causes of this phenomenon, it is necessary to analyse risk factors and the way of caring for pregnant women in these cases, and then, based on experience, available scientific studies and algorithms used at maternal-foetal medicine centres around the world, and later, draw appropriate conclusions. The basis for the development of the management algorithm is a detailed interview and paying attention to the conditions predisposing to an unfavourable obstetric outcome, as well as thorough physical examination.

The term “perinatal mortality” includes stillbirths and deaths of newborns in the first week of life, weighing at least 500 g (birth weight unknown) or born after the 22nd week of gestation, or reaching a body length of at least 25 cm (top of the skull to the heel). The perinatal mortality rate in 1999 was 10.8 per thousand and then gradually decreased, reaching 4.35 per thousand in 2018.

“Newborn mortality rate” is the number of neonatal deaths (from birth to 27 days after birth) per 1,000 live births. A similar trend is observed in neonatal mortality and morbidity — in 2018, the mortality rate was 3.8 per thousand, and the neonatal mortality rate was 2.8 per thousand [13]. The key issue for drawing clinically relevant conclusions is a large study group. Xiong et al. [14] accessed history data from 66,494 stillbirths. The observation period also covered 5 years, and the stillbirth rate was 1.9%. During this time, 6,970,032 deliveries took place.

In a 5-year follow-up by Kumar M et al. [15], a slightly higher percentage of stillbirths was shown, i.e., 2.6% (1,239 out of 46,816 cases). There were 2,597 foetal deaths in England and Wales in 2021. In a 2021 report published by UK Perinatal Surveillance, stillbirth rates decreased by 21% (from 4.20 per thousand in 2013 to 3.33 in 2020). Thus, approximately 605 fewer stillbirths were recorded in 2020 [16].

In 2020, 20,854 foetal deaths were reported in the United States after 20 weeks of gestation. Since 2019, a 3% decrease has been recorded (21,478) [17]. Analysing the statistics from 2020, 1,231 stillbirths were registered in Poland [11]. Documentation from 2015–2020 at 11 maternity centres in Poland provided information on 142,662 deliveries, during which a dead foetus was born in 761 cases (0.5%). In the British Isles, 73% of intrauterine deaths involved premature infants between 22–37 weeks of gestation, and 34% of them — extremely premature infants between 22 + 0 and 27 + 6 weeks of gestation [16].

In 2020, the foetal mortality rate after 20 weeks of gestation was 5.74 per thousand in the US. This did not significantly differ from the data found for 2019 (5.7/1,000). Mortality has decreased by 23% since 1990 (7.49/1,000) The rate of early foetal mortality (20–27 weeks of gestation) has remained essentially unchanged between 2019 (2.98/1,000) and 2020 (2.97/1,000). This indicator has decreased by 6% since 2014. Late foetal mortality (> 28 weeks of gestation) was 2.78 per thousand in 2020, which was not significantly different from 2019 (2.73/1000). The rate of late foetal mortality has been basically unchanged since 2014 [17].

In Poland, 52% of stillbirths occurred in primiparous women (55% below 30 weeks of gestation, i.e., in group 1, and as much as 50% above 30 weeks of gestation, i.e., group 2). With each subsequent pregnancy, the risk of stillbirth decreased (26% vs 27% stillbirth during the 2nd delivery, 13% vs 15% in the 3rd delivery). The majority of stillbirths were vaginal, 87% < 30 weeks of gestation, 77% > 30 weeks of gestation, and these were predominantly male foetuses < 30 gestation weeks (57.2% comprised males). On the other hand, girls died significantly more often > 30 weeks of pregnancy (53% of deaths in females vs 46.9% in males).

Similar results are presented by statistics from the United States. Male foetuses died 5% more often than that of female, regardless of gestational age (5.88 vs 5.59 per thousand) [17]. The greatest number of foetal deaths concerned mothers < 15 and > 45 years of age (13.42 vs 12.20 per thousand), i.e., three times more than in women aged 15–45.

In the USA, deaths in twin pregnancies were 2–3 times more frequent (12.12 per thousand) than in single pregnancies (5.51 per thousand) [17]. In Great Britain, there has been a 12% reduction in foetal deaths from twin pregnancies since 2016 [16]. In Great Britain, the highest infant death rate per 1,000 births (8.1 per thousand) concerned children of black mothers [16].

In the United States, black women are more than twice as likely to stillbirth than their white counterparts. However, the reasons for this phenomenon are not entirely clear. They are most likely to be found in frequent infections. Black women usually miscarry < 24 weeks or endure stillbirth [18, 19].

According to 2017 data from the CDC (Centre for Disease Control), there are large differences in stillbirth rates between different ethnic groups. These are the rates per 1,000 live and stillbirths: non-Hispanic blacks — 10.32, American Indians, Alaska Natives — 7.22, Hispanics — 5.01, non-Hispanic whites — 4.89, Asians — 4.29 [20].

Women who had experienced financial, emotional or other personal stress in the year before giving birth were at a greater risk of experiencing a stillbirth. Smoking tobacco or marijuana, taking painkillers or using illicit drugs during pregnancy is associated with a 2- to 3-fold risk of stillbirth [16–18].

In our analysis, it was found that the BMI of a mother carrying a dead foetus did not differ whether the foetal death occurred < 30 Hbd (mean BMI 23) or > 30 Hbd (mean BMI 24). The average body mass at admission to hospital was 73 kg (71 kg in group I1 vs 76 kg in group 2), and weight gain during pregnancy was < 6 kg in group 1 and 11 > in group 2. In foreign analyses, foetal death was much more common in overweight and obese mothers. The cause of death was determined in 43.38% of stillbirth cases, in the majority of full-term pregnancies (46%).

Although the percentage of stillbirths for unknown reasons has decreased, it is still the largest group of deaths in the UK, USA and Poland (as much as 33% of deaths, i.e., 1.08 per thousand). The SCRN (Stillbirth Collaborative Research Network) analysed over 500 cases of stillbirths that took place at 59 medical centres in the United States over a period of 2.5 years. In almost a quarter of these cases, scientists were unable to determine the probable or even possible cause of foetal death. In addition, many stillbirths had more than one probable cause.

The probable causes and contributing factors of stillbirth identified in this study are listed below in order from those most to least common:

  1. Complications with pregnancy and childbirth. These caused almost every third stillbirth. These complications included preterm delivery, twin and triplet pregnancies, and premature placental abruption. Complications related to pregnancy and childbirth were more frequent causes of stillbirths before 24 weeks.
  2. Almost a quarter of stillbirths were probably caused by problems with the placenta: incorrect implantation or too small placental exchange area. Deaths usually occurred after 24 weeks of gestation.
  3. Birth defects of the foetus. In more than 1 in 10 stillbirths, the foetus had a genetic or structural birth defect that likely caused its death.
  4. In more than 1 in 10 stillbirths, the death was probably due to foetal or placenta infection, or a serious infection in the mother. Infections were a more frequent cause of foetal deaths < 24 weeks of gestation. Bacterial infections caused by group B streptococci, E. coli, Klebsiella, Enterococci, Haemophilus influenza, Chlamydia and Mycoplasma or Ureaplasma constituted the largest group.
  5. Umbilical cord complications — true knot, long or short umbilical cord being the cause of stillbirth, which is more common at the end of pregnancy.
  6. High maternal blood pressure — whether from chronic hypertension or preeclampsia — this also contributed to stillbirths. These types of stillbirths were more common towards the end of the 2nd trimester and the beginning of the 3rd one.
  7. Maternal chronic diseases, such as diabetes, were considered a probable or possible cause in less than 1 in 10 stillbirths.

In Great Britain, placental causes accounted for just over a third of foetal deaths (35% — 1.16 per thousand). Foetal defects accounted for 0.5 per thousand, while all foetal causes (CODAC — Causes of Death and Associated Conditions) accounted for 0.65–0.74 per thousand of deaths over 22 weeks of gestation [15, 16].

According to the Polish experience, among full-term foetuses > 30 weeks of gestation, the overwhelming majority of deaths were due to antenatal causes, such as placental-umbilical (21.9%) and acute foetal hypoxia (16.2%), rarely acute peripartum events (2.24%), while < 30 Hbd FGR (25.76%), placental-umbilical causes (25%) and acute intrapartum events much less frequently (3.06%).

Analysing maternal causes and chronic diseases, premature placental abruption is a moderately frequent cause of death of mature and immature foetuses (9.5% in group 1 vs 6.11% in group 1).

Fetal Growth Restriction was much more often the cause of foetal death < 30 Hbd (33.19 in group 1 vs 17.32% in group 2). Diet-compensated gestational diabetes more often concerned deaths of more mature foetuses, > 30 Hbd (6.15% in group 2 vs 3.93% in group 1), gestational diabetes with insulin therapy in similarly mature foetuses (1.75% in group 1 vs 5.59% in group 2).

Pregnancy-induced hypertension was more common in more mature foetuses (8.38% in group 2 vs 4.8% in group 2) and pre-gestational hypertension in less mature foetuses (5.03% in group 2 vs 7.42% in group 1). Preeclampsia was a rare cause of death, mainly < 30 Hbd (2.23% in group 2 vs 5.24% in group 1), HELLP syndrome even rarer (0.87% in group 1) while cholestasis of pregnancy was a very rare cause of death only in mature foetuses (1.66% in group 2).

CONCLUSIONS

The phenomenon of stillbirth is a huge problem, both in the diagnostic and therapeutic context. The presented data clearly show how important meticulousness is in keeping medical records. Without a thorough physical examination and additional tests, it is not possible to detect or prevent the causes of stillbirths. Given the complexity of this problem, an algorithm should be developed taking the following factors into account: patient age (< 20 years and > 40 years), socioeconomic status, place of residence within the context of distance to hospitals, including clinical centres with the highest level of reference, level of health awareness among pregnant women in the area of pregnancy and perinatal preventative measures and the quality of health care, including perinatological and obstetric care.

The foetal mortality rate is decreasing every year. At the greatest risk are women < 15 and > 45 years of age, primiparous, with first pregnancy, especially having twins, of black race, burdened with chronic diseases, smoking, addicted to drugs and marijuana or painkillers, especially < 30 Hbd. The risk of foetal death is related to the mother’s race. The risk of foetal death is highest for blacks and the lowest for Asians.

The most common causes of death in the 1st trimester are chromosomal defects of the embryo (aberrations) and infections, in the 2nd trimester infections, birth defects and maternal diseases, while in full-term pregnancies, chronic maternal diseases, preeclampsia, gestational diabetes and pregnancy-induced hypertension as well as complications related to the delivery itself. In the case of stillbirth, it is crucial to collect a detailed history of the mother’s health, as well as to conduct additional examinations of the patient, foetus and postnatal. In Figure 8 presented below, a proposed diagnostic algorithm aimed at determining the cause of stillbirth is given.

Figure 8. Diagnostic algorithm for determining the cause(s) of stillbirth; CMV — cytomegalovirus; FGR — fetal growth restriction; CVD — chronic venous disease

As earlier mentioned, morphological assessment of the foetus is extremely important. Below is a draft chart that can help determine the cause of foetal death by assessing its anatomy. In order to understand the essence of problems related to stillbirths, a statistical database covering factors leading to intrauterine deaths should be developed and implemented, and efforts should be made to develop a reporting model on a uniform and comparable scale for other countries, in cooperation with foreign centres. It is worth following the example of the procedure proven in terms of reducing the percentage of stillbirths in other countries. According to the Australian model [13], which allowed for the lowest rate of intrauterine deaths, a national database on stillbirths should be created and funded, which would be maintained by a designated clinical unit.

In order to be able to implement the above assumptions, it is necessary to increase financial outlays on preventive programmes for the care of pregnant and postpartum patients. It is necessary to develop recommendations regarding the management of intrauterine deaths, which would present the principles of good clinical practice in this area in a clear and transparent way, based on algorithms.

Implementation of the above assumptions could contribute to a more thorough analysis of the problem and reduce its scale. Accurate statistics, detailed reporting of complications and, in particular, providing reliable medical and social care for pregnant women, could actually lead to a reduction in the number of stillbirths.

Article information and declarations
Conflict of interest

All authors declare no conflict of interest.

REFERENCES

  1. Metz TD, Berry RS, Fretts RC. Reddy UM, Turrentine MA. Obstetric care consensus. Management of stillbirth. Obstet Gynecol. 2020; 125(3): e110–e132.
  2. WHO Guidance 2021: Maternal and perinatal death and surveillance and response.
  3. National Center for Health Statistics. Model state vital statistics act and regulations.Atlanta, GA: Centers for Disease Control and Prevention; 1992. https://www.cdc.gov/nchs/data/misc/mvsact92b.pdf (16.09.2019).
  4. Zaręba-Szczudlik J, Romejko-Wolniewicz E, Malinowska-Polubiec A, et al. Analiza czynników ryzyka zgonów wewnątrzmacicznych płodów. Perinatol Neoanatol Ginekol. 2009; 2(3): 203–207.
  5. Frøen JF, Friberg IK, Lawn JE, et al. Lancet Ending Preventable Stillbirths Series study group. Stillbirths: progress and unfinished business. Lancet. 2016; 387(10018): 574–586, doi: 10.1016/S0140-6736(15)00818-1, indexed in Pubmed: 26794077.
  6. de Bernis L, Kinney MV, Stones W, et al. Lancet Ending Preventable Stillbirths Series study group, Lancet Ending Preventable Stillbirths Series Advisory Group. Stillbirths: ending preventable deaths by 2030. Lancet. 2016; 387(10019): 703–716, doi: 10.1016/S0140-6736(15)00954-X, indexed in Pubmed: 26794079.
  7. Lawn JE, Blencowe H, Waiswa P, et al. Lancet Ending Preventable Stillbirths Series study group, Lancet Stillbirth Epidemiology investigator group. Stillbirths: rates, risk factors, and acceleration towards 2030. Lancet. 2016; 387(10018): 587–603, doi: 10.1016/S0140-6736(15)00837-5, indexed in Pubmed: 26794078.
  8. American College of Obstetricians and Gynecologists. COVID-19 Vaccination Considerations for Obstetric–Gynecologic Care. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/covid-19-vaccination-considerations-for-obstetric-gynecologic-care?utm_source=higher- (15.09.2022).
  9. Flenady V, Wojcieszek AM, Middleton P, et al. Lancet Ending Preventable Stillbirths study group, Lancet Stillbirths In High-Income Countries Investigator Group. Stillbirths: recall to action in high-income countries. Lancet. 2016; 387(10019): 691–702, doi: 10.1016/S0140-6736(15)01020-X, indexed in Pubmed: 26794070.
  10. WHO. Global Health Obrervatory data repository. Stillbirth rate. Data by WHO region. https://apps.who.int/gho/data/view.main.STILLBIRTHGWHOREGIONv?lang=en (15.09.2022).
  11. Główny Urząd Statystyczny.Baza Demografia. Wyniki badań bieżących. https://demografia.stat.gov.pl/bazademografia/Tables.aspx (15.09.2022).
  12. Troszyński M, Maciejewski T, Wilczyńska A, et al. Przyczyny martwych urodzeń i zgonów noworodków w Polsce w latach 2007–2009. Ginekol Pol. 2011; 82: 598–601.
  13. Główny Urząd Statystyczny 2018. https://stat.gov.pl/obszary-tematyczne/roczniki-statystyczne/roczniki-statystyczne/rocznik-demograficzny-2018,3,12.html# (15.09.2022).
  14. Xiong T, Mu Yi, Liang J, et al. Hypertensive disorders in pregnancy and stillbirth rates: a facility-based study in China. Bull World Health Organ. 2018; 96(8): 531–539, doi: 10.2471/BLT.18.208447, indexed in Pubmed: 30104793.
  15. Kumar M, Vajala R, Bhutia P, et al. Factors contributing to late stillbirth among women with pregnancy hypertension in a developing country. Hypertens Pregnancy. 2020; 39(3): 236–242, doi: 10.1080/10641955.2020.1757699, indexed in Pubmed: 32396487.
  16. MBRRACE-UK Perinatal Mortality Surveillance Report for births in 2020.
  17. Gregory ECW, Valenzuela CP, Hoyert DL. Fetal Mortality: United States, 2020; Hyattsville, MD: National Center for Health Statistics. 2022. National Vital Statistics Reports. 2022; 71(4).
  18. Stillbirth Collaborative Research Network Writing Group. Causes of death among stillbirths. JAMA. 2011; 306(22): 2459–2468, doi: 10.1001/jama.2011.1823, indexed in Pubmed: 22166605.
  19. Hogue CJR, Parker CB, Willinger M, et al. A population-based case-control study of stillbirth: the relationship of significant life events to the racial disparity for African Americans. Am J Epidemiol. 2013; 177(8): 755–767, doi: 10.1093/aje/kws381, indexed in Pubmed: 23531847.
  20. CDC Center for Global Health 2017 Annual Report. https://www.cdc.gov/globalhealth/resources/reports/annual/pdf/CGH_Annual-Report_2017-h.pdf (15.09.2022).
  21. Khong T, Mooney E, Ariel I, et al. Sampling and definitions of placental lesions: amsterdam placental workshop group consensus statement. Archives Pathology Laboratory Med. 2016; 140(7): 698–713, doi: 10.5858/arpa.2015-0225-cc.